Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS
Two separate studies at ACC.25 explored data from the EARLY TAVR trial. One analysis included stroke findings that surprised researchers.
Dapagliflozin improves outcomes for elderly TAVR patients with heart failure
The positive data were presented as part of a late-breaking clinical trial at ACC.25 in Chicago. One cardiologist on stage for the presentation said these findings will impact the way he manages certain TAVR patients.
American Heart Association program leads to substantial improvements in stroke care
Cardiologist Gregg Fonarow, MD, reviewed decades of data and discussed the long-term impact of the AHA's Get With The Guidelines-Stroke program.
Bringing state-of-the-art healthcare to Florida heart patients
Naples Comprehensive Health is building up what it hopes will be a nationally recognized cardiology program. Robert Cubeddu, MD, and Dee Dee Wang, MD, spoke with Cardiovascular Business about the journey so far.
Society of Interventional Radiology seeks to bolster research funding for the specialty
During their annual meeting being held this week in Nashville, the society announced the launch of the SIR Foundation Endowment.

How much is too much? Older heart failure patients often go home on 10 or more prescriptions

Clinicians should consider the potential negative impact of prescribing so many medications at once, the study's authors noted.

Valve durability after 5 years: Sapien 3 TAVR outcomes comparable to SAVR

The Sapien 3 prosthesis continues to impress, though researchers must continue to monitor its performance as time goes on.

HHS officially extends COVID-19 public health emergency again ahead of upcoming expiration date

This is the third such renewal and will prolong the PHE into January, Secretary Alex Azar said.

TAVR safe for low-risk patients with bicuspid aortic valve disease

More research on long-term outcomes is still needed before TAVR can be recommended for such patients across the board.

2 new recalls announced for extended-release metformin due to contamination

More lots of extended-release metformin have been recalled due to high levels of NDMA, a contaminant associated with cancer.

Hydroxychloroquine ‘not an effective treatment’ for COVID-19, leads to longer hospital stays

The study's authors explored data from more than 1,500 patients treated with hydroxychloroquine and more than 3,000 who received usual care.

Calculating COVID Countermeasures at Scale

In response to the COVID pandemic, most hospitals have adopted a policy of curtailing elective clinical and surgical services while preserving urgent/semi-urgent and inpatient care in order to conserve personal protective equipment (PPE), and to reduce patient and personnel exposure to infection, while providing for surge capacity in the event of wider dissemination.

Why metoprolol should be the beta-blocker of choice for heart attack patients

While metoprolol was linked with limiting infarct size, two other beta-blockers—atenolol and propranolol—were not associated with such improvements.

Clinical

New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS

Dapagliflozin improves outcomes for elderly TAVR patients with heart failure

American Heart Association program leads to substantial improvements in stroke care

Bringing state-of-the-art healthcare to Florida heart patients

Society of Interventional Radiology seeks to bolster research funding for the specialty